Abstract:Hepatocellular carcinoma (HCC) is highly malignant and prone to metastasize due to the heterogeneous and immunosuppressive tumor microenvironment (TME). Programmed cell deaths (PCDs) including apoptosis, ferroptosis, and pyroptosis routinely occur in the HCC TME and participate in tumorigenesis. However, how apoptosis, ferroptosis, and pyroptosis are involved in constructions of the immunosuppressive TME and their underlying cross-talk remains to be further unveiled. In this work, we deciphered the immunosuppressive landscape of HCC TME, which demonstrated high expressions of inhibitory checkpoint molecules and infiltration of protumor immune cells but low infiltration of antitumor effector immune cells. Further investigations unequivocally revealed that marker genes of apoptosis, ferroptosis, and pyroptosis are closely correlated with expressions and infiltrations of inhibitory checkpoint molecules and immune cells and that higher “-optosis” links to poorer patient prognosis. Notably, such three types of “-optosis” interact with each other at both the gene and protein levels, suggesting that they conspiringly induce the establishment of the immunosuppressive HCC TME. Interestingly, examinations of circulating γδ T cells in HCC patients revealed a noticeable dysfunction phenotype. The strikingly elevated ratio of the Vδ1+ versus the Vδ2+ subset suggested that the Vδ1+/Vδ2+ ratio would be a potential biomarker for the diagnosis and prognosis in HCC patients. Altogether, this work thoroughly decrypted the underlying correlations between apoptosis, ferroptosis, and pyroptosis and the formation of immunosuppressive HCC TME and, meanwhile, indicated that allogeneic Vδ2+ γδ T-cell transfer would be a promising adjuvant strategy for renormalizing circulating γδ T cell and thus achieving sound clinical efficacy against HCC.

Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review)

Ferroptosis, Necroptosis, and Pyroptosis in Anticancer Immunity

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy

Ferroptosis: insight into the treatment of hepatocellular carcinoma

Immunotherapy of Hepatocellular Carcinoma: Recent Progress and New Strategy.

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy

Ferroptosis: a New Promising Target for Hepatocellular Carcinoma Therapy

Ferroptosis in hepatocellular carcinoma: from bench to bedside

The Application of Nanoparticles-Based Ferroptosis, Pyroptosis and Autophagy in Cancer Immunotherapy

Immunomodulation of cuproptosis and ferroptosis in liver cancer

Ferroptosis in Hepatocellular Carcinoma: Mechanisms and Targeted Therapy

Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti‐PD‐1/PD‐L1 cancer immunotherapy

Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy

Ferroptosis: a new hunter of hepatocellular carcinoma

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis and Its Interaction with Tumor Immune Microenvironment in Liver Cancer.

Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects

Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and Γδ T-Cell Imbalance.

Current Progress of Ferroptosis Study in Hepatocellular Carcinoma

Ferroptosis in hepatocellular carcinoma, from mechanism to effect